AvenCell Therapeutics
Pre-clinicalAvenCell Therapeutics develops next-generation CAR-T cell therapies for cancer.
Founded
2020
Focus
AntibodiesBiologicsCell & Gene Therapy
About
AvenCell Therapeutics develops next-generation CAR-T cell therapies for cancer.
Funding History
1Total raised: $60M
Series A$60MRA Capital ManagementJan 15, 2023
Company Info
TypePrivate
Founded2020
LocationMunich, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile